Evidence map›Paper›PMID 34861817›Full record

ArticleBMC genomics2021

Integrated omics analysis reveals sirtuin signaling is central to hepatic response to a high fructose diet.

Laura A Cox, Jeannie Chan, Prahlad Rao, Zeeshan Hamid, Jeremy P Glenn, Avinash Jadhav, Vivek Das, Genesio M Karere, Ellen Quillen, Kylie Kavanagh and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Plasma and CSF biomarkers of aging and cognitive decline in Caribbean vervets.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Laura A CoxCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA. laurcox@wakehealth.edu.
Jeannie ChanCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA.
Prahlad RaoUniversity of Tennessee Health Science Center, TN, Memphis, USA.
Zeeshan HamidCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA.
Jeremy P GlennDepartment of Genetics, Texas Biomedical Research Institute, 78245, San Antonio, TX, USA.
Avinash JadhavCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA.
Vivek DasNovo Nordisk Research Center, Seattle, WA, USA.
Genesio M KarereCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA.
Ellen QuillenCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA.
Kylie KavanaghCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA.
Michael OlivierCenter for Precision Medicine, Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, NRC, G-floor, NC, 27157, Winston-Salem, USA.
Wake Forest University · USTexas Biomedical Research Institute · USNovo Nordisk (United States) · USUniversity of Tennessee Health Science Center · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Vervet Research Colony as a Biomedical ResourceP40OD010965 · OD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Matthew Jorgensen · 2012 to 2026
$14.6M
Womb to Tomb: Developmental Programming and Aging Interactions in PrimatesU19AG057758 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CLARKE, GEOFFREY DAVID, COX, LAURA A · 2018 to 2024
$13.2M
Identification of Molecular Mechanisms Underlying Early AtherosclerosisK01HL130697 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KARERE, GENESIO · 2016 to 2021
$647k
Chaperone Proteins in a Primate Model of Age-Related Metabolic DiseaseK01AG033641 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KAVANAGH, KYLIE · 2009 to 2013
$567k
Integrative multi-omic investigation of age-related changes in trabecular boneK01AG056663 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI QUILLEN, ELLEN ELIZABETH · 2018 to 2021
$377k
NCATS NIH HHS UL1 TR001420NCATS NIH HHS UL1TR001420NHLBI NIH HHS K01 HL130697NHLBI NIH HHS K01HL130697NIA NIH HHS K01 AG033641NIA NIH HHS K01AG033641NIA NIH HHS K01 AG056663NIA NIH HHS K01AG056663NIA NIH HHS U19 AG057758NIH HHS P40 OD010965NIH HHS P51 OD011133NIH Office of the Director P40OD010965
6 · The paper itself

Abstract

backgroundDietary high fructose (HFr) is a known metabolic disruptor contributing to development of obesity and diabetes in Western societies. Initial molecular changes from exposure to HFr on liver metabolism may be essential to understand the perturbations leading to insulin resistance and abnormalities in lipid and carbohydrate metabolism. We studied vervet monkeys (Clorocebus aethiops sabaeus) fed a HFr (n=5) or chow diet (n=5) for 6 weeks, and obtained clinical measures of liver function, blood insulin, cholesterol and triglycerides. In addition, we performed untargeted global transcriptomics, proteomics, and metabolomics analyses on liver biopsies to determine the molecular impact of a HFr diet on coordinated pathways and networks that differed by diet.

resultsWe show that integration of omics data sets improved statistical significance for some pathways and networks, and decreased significance for others, suggesting that multiple omics datasets enhance confidence in relevant pathway and network identification. Specifically, we found that sirtuin signaling and a peroxisome proliferator activated receptor alpha (PPARA) regulatory network were significantly altered in hepatic response to HFr. Integration of metabolomics and miRNAs data further strengthened our findings.

conclusionsOur integrated analysis of three types of omics data with pathway and regulatory network analysis demonstrates the usefulness of this approach for discovery of molecular networks central to a biological response. In addition, metabolites aspartic acid and docosahexaenoic acid (DHA), protein ATG3, and genes ATG7, and HMGCS2 link sirtuin signaling and the PPARA network suggesting molecular mechanisms for altered hepatic gluconeogenesis from consumption of a HFr diet.

Indexed as

Insulin ResistanceSirtuinsAnimalsChlorocebus aethiopsDietFructoseLiverFructoseSirtuinsDietHigh fructose dietIntegrated omicsLiver metabolismMetabolomicsmiRNAPathway analysisProteomicsTranscriptomicsVervet

Identifiers

PMID34861817
PMCPMC8641221
OpenAlexW3216833894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.